BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3568291)

  • 1. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements.
    Schömig A; Fischer S; Kurz T; Richardt G; Schömig E
    Circ Res; 1987 Feb; 60(2):194-205. PubMed ID: 3568291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue.
    Kurz T; Richardt G; Hagl S; Seyfarth M; Schömig A
    J Mol Cell Cardiol; 1995 May; 27(5):1161-72. PubMed ID: 7473774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular sodium and chloride depletion enhances nonexocytotic noradrenaline release induced by energy deficiency in rat heart.
    Kurz T; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):265-9. PubMed ID: 2812038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.
    Kurz T; Richardt G; Seyfarth M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):7-16. PubMed ID: 8832582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effect of nicotine on cardiac noradrenaline release during metabolic blockade.
    Richardt G; Brenn T; Seyfarth M; Haass M; Schömig E; Schömig A
    Basic Res Cardiol; 1994; 89(6):524-34. PubMed ID: 7702541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia.
    Richardt G; Lumpp U; Haass M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):50-5. PubMed ID: 2314483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal sodium homoeostatis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart.
    Schömig A; Kurz T; Richardt G; Schömig E
    Circ Res; 1988 Jul; 63(1):214-26. PubMed ID: 3383376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of digitalis glycosides on norepinephrine release in the heart. Dual mechanism of action.
    Kranzhöfer R; Haass M; Kurz T; Richardt G; Schömig A
    Circ Res; 1991 Jun; 68(6):1628-37. PubMed ID: 2036716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release.
    Schömig A; Dart AM; Dietz R; Mayer E; Kübler W
    Circ Res; 1984 Nov; 55(5):689-701. PubMed ID: 6488489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of noradrenaline release in the anoxic heart of the rat.
    Du XJ; Dart AM
    Cardiovasc Res; 1993 Nov; 27(11):2011-5. PubMed ID: 8287411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.
    Haass M; Hock M; Richardt G; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):509-15. PubMed ID: 2615846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic requirements for release of endogenous noradrenaline during myocardial ischaemia and anoxia.
    Dart AM; Riemersma RA; Schömig A; Ungar A
    Br J Pharmacol; 1987 Jan; 90(1):43-50. PubMed ID: 3814923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine and dihydroxyphenylglycol effluxes from sympathetic nerve endings during hypoxia and reoxygenation in the isolated rat heart.
    Chahine R; Nadeau R; Lamontagne D; Yamaguchi N; de Champlain J
    Can J Physiol Pharmacol; 1994 Jun; 72(6):595-601. PubMed ID: 7954091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists and cardiac noradrenaline release in ischemia.
    Richardt G; Haass M; Schömig A
    J Mol Cell Cardiol; 1991 Mar; 23(3):269-77. PubMed ID: 1880812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.
    Richardt G; Waas W; Kranzhöfer R; Mayer E; Schömig A
    Circ Res; 1987 Jul; 61(1):117-23. PubMed ID: 3608108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts.
    Kurz T; Offner B; Schreieck J; Richardt G; Tölg R; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):491-6. PubMed ID: 8751077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart.
    Carlsson L; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):508-18. PubMed ID: 3437922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines in myocardial ischemia. Systemic and cardiac release.
    Schömig A
    Circulation; 1990 Sep; 82(3 Suppl):II13-22. PubMed ID: 2203558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of noradrenaline from isolated rat tail artery induced by bafilomycin A1.
    Palatý V
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):431-7. PubMed ID: 8935710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical role of neuronal uptake for the locally mediated release of endogenous noradrenaline in the ischemic myocardium.
    Schömig A; Dart AM; Dietz R; Kübler W; Mayer E
    J Cardiovasc Pharmacol; 1985; 7 Suppl 5():S40-4. PubMed ID: 2410734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.